Potential catalysts in therapeutics
Bruce A. Luxon – 27 August 2014
Bruce A. Luxon – 27 August 2014
Nancy Reau – 25 August 2014 – Watch a video presentation of this article
Valentin Fuhrmann, Andreas Drolz, Karoline Rutter, Thomas Horvatits – 25 August 2014 – Watch a video presentation of this article
Julie Heimbach – 25 August 2014
Jean‐François Dufour – 25 August 2014
Nancy Reau – 25 August 2014 – Watch a video presentation of this article
Karen L. Krok – 25 August 2014 – Watch a video presentation of this article
Francis Y. Yao, Bilal Hameed, Neil Mehta, John P. Roberts – 25 August 2014
Robert J. Wong, Robert G. Gish, Aijaz Ahmed – 25 August 2014 – The prioritization of liver transplantation (LT) for patients with end‐stage liver disease uses the Model for End‐Stage Liver Disease (MELD), which attempts to identify the sickest patients and thereby those who are in greatest need for LT. Hepatic encephalopathy (HE) is not included in MELD, and severity of liver disease and risk of wait‐list removal or wait‐list death may be underestimated by MELD in patients with HE.
Vivek N. Iyer – 25 August 2014 – Watch a video presentation of this article